Hopkinson Craig C.
- SEC CIK
- 0001730048
In the past year, 14 open-market sale filings worth $3.94M and no purchases.
Current role at each company
- ALKS Alkermes plc.EVP R&D, Chief Medical Officeras of Sep 1, 2026
- ALBO Albireo Pharma, Inc.Directoras of Mar 2, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $3.94M
- 14 filings
- Net
- −$3.94M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Hopkinson Craig C. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ALKS Alkermes plc.
EVP R&D, Chief Medical Officer23 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 (view filing)7:08 PM ET | Sep 1 | Same day | Hopkinson Craig C.EVP R&D, Chief Medical Officer | SSale | −9.00K | $46.99 | −$422.9K | −12.1%65.4K after | 10b5-1 |
| Aug 3, 2026 (view filing)7:12 PM ET | Aug 3 | Same day | Hopkinson Craig C.EVP R&D, Chief Medical Officer | SSale | −9.00K | $48.58 | −$437.2K | −11.5%69.4K after | 10b5-1 |
| Jul 1, 2026 (view filing)6:29 PM ET | Jul 1 | Same day | Hopkinson Craig C.EVP R&D, Chief Medical Officer | SSale | −9.00K | $51.51 | −$463.6K | −10.9%73.4K after | 2 lots10b5-1 |
| Jun 1, 2026 (view filing) | Jun 1 | Same day | Hopkinson Craig C.EVP R&D, Chief Medical Officer | SSale | −9.00K | $41.67 | −$375.0K | −10.4%77.4K after | 10b5-1 |
| May 1, 2026 (view filing) | May 1 | Same day | Hopkinson Craig C.EVP R&D, Chief Medical Officer | SSale | −9.00K | $33.40 | −$300.6K | −10.0%81.4K after | 10b5-1 |
| Apr 1, 2026 (view filing) | Apr 1 | Same day | Hopkinson Craig C.EVP R&D, Chief Medical Officer | SSale | −9.00K | $35.51 | −$319.6K | −9.5%85.4K after | 10b5-1 |
| Mar 4, 2026 (view filing) | Mar 2 | 2 days | Hopkinson Craig C.EVP R&D, Chief Medical Officer | SSale | −9.00K | $29.72 | −$267.5K | −9.1%89.4K after | 10b5-1 |
| Feb 2, 2026 (view filing) | Feb 2 | Same day | Hopkinson Craig C.EVP R&D, Chief Medical Officer | SSale | −9.00K | $33.93 | −$305.4K | −13.5%57.7K after | 2 lots10b5-1 |
| Jan 8, 2026 (view filing) | Jan 8 | Same day | Hopkinson Craig C.EVP R&D, Chief Medical Officer | SSale | −5.00K | $30.00 | −$150.0K | −7.5%61.7K after | 10b5-1 |
| Jan 2, 2026 (view filing) | Jan 2 | Same day | Hopkinson Craig C.EVP R&D, Chief Medical Officer | SSale | −4.00K | $28.00 | −$112.0K | −6.1%61.7K after | 10b5-1 |